32 reports

Cardiovascular diseases accounts for highest patient pool in the country, after HIV/ AIDS.

  • General Medicine And Specialty Medicine
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Teleflex Incorporated

ABBOTT MAINLY FOCUSES ON SIX CORE THERAPEUTIC AREAS SUCH RHEUMATOID ARTHRITIS, HIV/ AIDS, RESPIRATORY INFECTIONS, CANCER, DIABETES AND GENETIC CONDITIONS.

  • General Medicine And Specialty Medicine
  • World
  • Market Size
  • CareDx, Inc.
  • Illumina, Inc.

(USA) ##.

  • General Medicine And Specialty Medicine
  • Europe
  • United States
  • World
  • Market Shares

## ## ## ## Merck & Co Inc ## ## ## ## ## Groupe Francophone des Myelodysplasies ## ## ## ## ## Daiichi Sankyo Co Ltd ## ## ## ## ## CTI BioPharma Corp ## ## ## ## ## Celerion Inc ## ## ## ## ## Bristol-Myers Squibb C

  • Cancer
  • General Medicine And Specialty Medicine
  • Leukemia
  • Therapy
  • Celgene Corporation

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Therapy
  • World
  • Product Initiative
  • Celgene Corporation
  • BONE MARROW TRANSPLANT REJECTION - PIPELINE BY GLAXOSMITHKLINE PLC
  • GRAFT VERSUS HOST DISEASE (GVHD) - PIPELINE BY GILEAD SCIENCES INC

The company offers products in various therapeutic areas including cardiovascular, respiratory, inflammation, liver diseases, cancer and HIV/ AIDS.

  • General Medicine And Specialty Medicine
  • Healthcare
  • United States
  • Company
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • General Medicine And Specialty Medicine
  • Targeted Therapy
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG

## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## Sarah Cannon Research Institute LLC ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## AstraZeneca Plc ## ## ## ## ## ##

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Leukemia
  • Monoclonal Antibody
  • Pharmaceutical
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • General Medicine And Specialty Medicine
  • Liver Transplant
  • Novartis AG
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Heart Transplant
  • Pharmaceutical
  • World
  • Novartis AG

The prominent features of this report are - ##.

  • Blood Disease
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Lymphoma
  • United States
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## ## Bristol-Myers Squibb Co ## ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## ## Chiesi Farmaceutici SpA ## ## ## ## ## ## ## ## ## Alexion Pharmaceuticals Inc ## ## ## ##

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Novartis AG

One MDS patient experienced a PR.

  • General Medicine And Specialty Medicine
  • Leukemia
  • Oncology
  • Pharmaceutical
  • World
  • 5. All the trials included are unique trials.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Takeda Pharmaceutical Company Ltd ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Neopharm Ltd ## ## ## ## ## ## ## ## Mallinckrodt Plc ## ## ## ## ## ## ## ## Bellicum Pharmaceutic

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Pharmaceutical
  • Transplantation
  • World

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Leukemia
  • Monoclonal Antibody
  • United States
  • World
  • 5. All the trials included are unique trials.

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Canada Source: GlobalData' s Phar

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Transplantation
  • World
  • Product Initiative

## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma Intellige

  • Blood Disease
  • Cancer
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG

Seven of these ## patients responded (## CR, ## VGPR, and ## PRs) for an ORR of ##%.

  • General Medicine And Specialty Medicine
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative

CLINICAL TRIAL PROFILE SNAPSHOTS Note: ##.

  • Cancer
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Leukemia
  • Novartis AG
  • Clinical Trial profile. 242 Trial Title
  • Clinical Trial Profile Snapshots

Amarex Clinical Research, LLC ## May 2016 ## Dec 2017 C-C Chemokine Receptor Type ## (CHEMR## or HIV ## Fusion Coreceptor or CD## or CCR##) Antagonist C-C Chemokine Receptor Type ## (CHEMR## or HIV ## Fusion Coreceptor or CD## or CCR##) Clinical Trial profile. ## Tri

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Pharmaceutical
  • World
  • Product Initiative

Food And Drug Administration (FDA) an application for orphan drug designation for the use of PRO ## (humanized monoclonal antibody to CCR##) in the pretreatment of HIV Type-## (HIV-##) infection in treatment-naive adults.

  • General Medicine And Specialty Medicine
  • Healthcare
  • Monoclonal Antibody
  • Transplantation
  • United States

The study findings were presented at the ##th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome.

  • General Medicine And Specialty Medicine
  • Healthcare
  • Lymphoma
  • Transplantation
  • United States
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Blood Disease
  • General Medicine And Specialty Medicine
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Clinical Trial Profile Snapshots

## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## Source

  • Blood Disease
  • Clinical Trial
  • General Medicine And Specialty Medicine
  • World
  • Product Initiative

IN ITS MOST RECENTLY PUBLISHED DATA, THE CENTERS FOR DISEASE CONTROL AND PREVENTION ESTIMATES OVER ##. ## MILLION PEOPLE ARE LIVING WITH HIV/ AIDS IN THE U. S.

  • General Medicine And Specialty Medicine
  • Northern Europe
  • United Kingdom
  • Forecast
  • Market Size

The prominent features of this report are - ##.

  • General Medicine And Specialty Medicine
  • Leukemia
  • Therapy
  • World
  • Product Initiative

The study findings were presented at the ##th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Rome.

  • General Medicine And Specialty Medicine
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Product Initiative